Cargando…
Synthesis and crystal structure of (1,8-naphthyridine-κ(2) N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2) N (2),C (1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate
The solvated title salt, [Ir(C(9)H(7)N(2))(2)(C(8)H(6)N(2))]PF(6)·CH(2)Cl(2), was obtained from the reaction between 1,8-naphthyridine (NAP) and an orthometalated iridium(III) precursor containing a 1-phenylpyrazole (ppz) ligand. The asymmetric unit comprises one [Ir(ppz)(2)(NAP)](+) cation, one PF...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944085/ https://www.ncbi.nlm.nih.gov/pubmed/31921457 http://dx.doi.org/10.1107/S2056989019016773 |
_version_ | 1783484991307513856 |
---|---|
author | Ye, Yunfeng Tang, Guodong Qian, Jun |
author_facet | Ye, Yunfeng Tang, Guodong Qian, Jun |
author_sort | Ye, Yunfeng |
collection | PubMed |
description | The solvated title salt, [Ir(C(9)H(7)N(2))(2)(C(8)H(6)N(2))]PF(6)·CH(2)Cl(2), was obtained from the reaction between 1,8-naphthyridine (NAP) and an orthometalated iridium(III) precursor containing a 1-phenylpyrazole (ppz) ligand. The asymmetric unit comprises one [Ir(ppz)(2)(NAP)](+) cation, one PF(6) (−) counter-ion and one CH(2)Cl(2) solvent molecule. The central Ir(III) atom of the [Ir(ppz)(2)(NAP)](+) cation is distorted-octahedrally coordinated by four N atoms and two C atoms, whereby two N atoms stem from the NAP ligand while the ppz ligands ligate through one N and one C atom each. In the crystal, the [Ir(ppz)(2)(NAP)](+) cations and PF(6) (−) counter-ions are connected with each other through weak intermolecular C—H⋯F hydrogen bonds. Together with an additional C—H⋯F interaction involving the solvent molecule, a three-dimensional network structure is formed. |
format | Online Article Text |
id | pubmed-6944085 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-69440852020-01-09 Synthesis and crystal structure of (1,8-naphthyridine-κ(2) N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2) N (2),C (1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate Ye, Yunfeng Tang, Guodong Qian, Jun Acta Crystallogr E Crystallogr Commun Research Communications The solvated title salt, [Ir(C(9)H(7)N(2))(2)(C(8)H(6)N(2))]PF(6)·CH(2)Cl(2), was obtained from the reaction between 1,8-naphthyridine (NAP) and an orthometalated iridium(III) precursor containing a 1-phenylpyrazole (ppz) ligand. The asymmetric unit comprises one [Ir(ppz)(2)(NAP)](+) cation, one PF(6) (−) counter-ion and one CH(2)Cl(2) solvent molecule. The central Ir(III) atom of the [Ir(ppz)(2)(NAP)](+) cation is distorted-octahedrally coordinated by four N atoms and two C atoms, whereby two N atoms stem from the NAP ligand while the ppz ligands ligate through one N and one C atom each. In the crystal, the [Ir(ppz)(2)(NAP)](+) cations and PF(6) (−) counter-ions are connected with each other through weak intermolecular C—H⋯F hydrogen bonds. Together with an additional C—H⋯F interaction involving the solvent molecule, a three-dimensional network structure is formed. International Union of Crystallography 2020-01-01 /pmc/articles/PMC6944085/ /pubmed/31921457 http://dx.doi.org/10.1107/S2056989019016773 Text en © Ye et al. 2020 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Research Communications Ye, Yunfeng Tang, Guodong Qian, Jun Synthesis and crystal structure of (1,8-naphthyridine-κ(2) N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2) N (2),C (1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate |
title | Synthesis and crystal structure of (1,8-naphthyridine-κ(2)
N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2)
N
(2),C
(1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate |
title_full | Synthesis and crystal structure of (1,8-naphthyridine-κ(2)
N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2)
N
(2),C
(1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate |
title_fullStr | Synthesis and crystal structure of (1,8-naphthyridine-κ(2)
N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2)
N
(2),C
(1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate |
title_full_unstemmed | Synthesis and crystal structure of (1,8-naphthyridine-κ(2)
N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2)
N
(2),C
(1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate |
title_short | Synthesis and crystal structure of (1,8-naphthyridine-κ(2)
N,N′)[2-(1H-pyrazol-1-yl)phenyl-κ(2)
N
(2),C
(1)]iridium(III) hexafluoridophosphate dichloromethane monosolvate |
title_sort | synthesis and crystal structure of (1,8-naphthyridine-κ(2)
n,n′)[2-(1h-pyrazol-1-yl)phenyl-κ(2)
n
(2),c
(1)]iridium(iii) hexafluoridophosphate dichloromethane monosolvate |
topic | Research Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944085/ https://www.ncbi.nlm.nih.gov/pubmed/31921457 http://dx.doi.org/10.1107/S2056989019016773 |
work_keys_str_mv | AT yeyunfeng synthesisandcrystalstructureof18naphthyridinek2nn21hpyrazol1ylphenylk2n2c1iridiumiiihexafluoridophosphatedichloromethanemonosolvate AT tangguodong synthesisandcrystalstructureof18naphthyridinek2nn21hpyrazol1ylphenylk2n2c1iridiumiiihexafluoridophosphatedichloromethanemonosolvate AT qianjun synthesisandcrystalstructureof18naphthyridinek2nn21hpyrazol1ylphenylk2n2c1iridiumiiihexafluoridophosphatedichloromethanemonosolvate |